ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.83
0.43%
US Tech 100
17,166.00
1.81%
S&P 500
5,064.20
0.91%
US Dollar vs CAD
1.36705
-0.39%
Bitcoin
59,228.92
1.70%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Maxcyte Inc (MXCT)

  7. Maxcyte Inc (MXCT) News

MXCT

Maxcyte (MXCT)

Maxcyte Inc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:MXCT
DateTimeSourceHeadlineSymbolCompany
05/01/202411:04AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
04/10/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
04/03/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Total Voting Rights and Block Listing ReturnLSE:MXCTMaxcyte Inc
04/02/20249:19AMAlliance NewsAlliance NewsTRADING UPDATES: MaxCyte inks deal with Be Bio; Orcadian firms farmoutLSE:MXCTMaxcyte Inc
04/02/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
04/02/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
03/20/20245:16AMRNS Regulatory NewsMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR DealingLSE:MXCTMaxcyte Inc
03/20/20245:05AMRNS Regulatory NewsMaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR DealingLSE:MXCTMaxcyte Inc
03/13/20246:54AMAlliance NewsAlliance NewsIN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25%LSE:MXCTMaxcyte Inc
03/13/20242:05AMRNS Regulatory NewsMaxCyte, Inc. Filing of form 10-K for FY ended December 31, 2023LSE:MXCTMaxcyte Inc
03/13/20242:00AMRNS Regulatory NewsMaxCyte, Inc. Reports Q4 & FY 2023 Financial ResultsLSE:MXCTMaxcyte Inc
03/12/20243:05PMUK RegulatoryMaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and Reiterates 2024 GuidanceLSE:MXCTMaxcyte Inc
03/06/20242:58AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
03/05/20242:43PMAlliance NewsAlliance NewsEARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profitLSE:MXCTMaxcyte Inc
03/05/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Preliminary FY Results & 2024 GuidanceLSE:MXCTMaxcyte Inc
03/04/20243:05PMUK RegulatoryMaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary ResultsLSE:MXCTMaxcyte Inc
03/01/202411:57AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
02/29/20243:21AMRNS Regulatory NewsMaxCyte, Inc. Exercise of options and PDMR dealingLSE:MXCTMaxcyte Inc
02/26/20241:00AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
02/09/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Notice of ResultsLSE:MXCTMaxcyte Inc
02/09/20247:05AMUK RegulatoryMaxCyte to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024 and Participate in Upcoming Investor ConferencesLSE:MXCTMaxcyte Inc
02/01/20243:24AMRNS Regulatory NewsMaxCyte, Inc. Total Voting RightsLSE:MXCTMaxcyte Inc
01/31/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Director/PDMR ShareholdingLSE:MXCTMaxcyte Inc
01/30/20248:29AMRNS Regulatory NewsMaxCyte, Inc. Holding(s) in CompanyLSE:MXCTMaxcyte Inc
01/30/20247:58AMAlliance NewsAlliance NewsIN BRIEF: MaxCyte signs licencing deal with cell therapy company WugenLSE:MXCTMaxcyte Inc
01/30/20247:05AMRNS Regulatory NewsMaxCyte, Inc. Signing of Strategic Platform LicenseLSE:MXCTMaxcyte Inc
01/30/20247:05AMUK RegulatoryMaxCyte and Wugen Sign Strategic Platform License to Expedite Scale-Up of Clinical and Commercial Manufacturing of Wugen’s Investigational Allogeneic, Off-the-Shelf Cell Therapies for CancersLSE:MXCTMaxcyte Inc
01/29/202411:56AMAlliance NewsAlliance NewsIN BRIEF: MaxCyte chief scientific officer leaves firmLSE:MXCTMaxcyte Inc
01/29/202410:52AMRNS Regulatory NewsMaxCyte, Inc. TR-1: Notification of major holdingsLSE:MXCTMaxcyte Inc
01/29/20241:00AMRNS Regulatory NewsMaxCyte, Inc. Filing of Form 8-KLSE:MXCTMaxcyte Inc
 Showing the most relevant articles for your search:LSE:MXCT

Your Recent History

NASDAQ
JAGX
Jaguar Health
USOTC
GSTC
Globestar Therapeutics (PK)
USOTC
BEGI
BlackStar Enterprise (PK)
USOTC
SPZI
Spooz (PK)
USOTC
TSOI
Therapeutic Solutions (PK)
USOTC
ILST
International Star (PK)
USOTC
ACRL
Atacama Resources (PK)
USOTC
VPLM
Voip Pal Com (QB)
NASDAQ
DJT
Trump Media and Technology
USOTC
BMXI
Brookmount Explorations (PK)
NASDAQ
HOLO
MicroCloud Hologram
NASDAQ
MULN
Mullen Automotive
NASDAQ
VERB
Verb Technology
USOTC
BABL
Buildablock (PK)
USOTC
FBEC
FBEC Worldwide (PK)
NASDAQ
AMRN
Amarin
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved